Can damp or mold-contaminated buildings cause ongoing inhalational exposure, while urine mycotoxin testing cannot prove the source or contamination?

Long-term residence in a water-damaged or mould-contaminated building can sustain inhalation exposure, but urinary mycotoxin results cannot determine whether that building is the source or establish mould-related illness.

Exposure and mechanisms

• Persistent dampness, water intrusion, condensation, and moisture within building materials promote fungal growth. During continued occupancy, contaminated materials can release spores, fungal cells, fragments, allergens, β-glucans, and mycotoxins into indoor air.
• Airflow, vibration, and disturbance aerosolize fungal material. Chamber studies found that fragment release can substantially exceed spore release for some fungi, and field work found mouldy basement air relatively enriched in fungal fragments. Particle-associated mycotoxins have also become airborne from mouldy wallpaper at building-relevant air speeds.
• This supports a plausible ongoing inhalational pathway, but does not quantify an individual’s cumulative dose, predict illness, or define a universally safe airborne fungal concentration.

Urine mycotoxin testing

• A positive urine mycotoxin result is not source-specific. It cannot distinguish dietary exposure—generally the principal source—from inhalation or other environmental routes, nor attribute exposure to a particular home or workplace.
• Spot urine results are affected by recent intake, collection timing, and toxin-specific clearance. For markers such as gliotoxin and mycophenolic acid, available evidence does not establish source-classification accuracy against quantified building exposures.
• CDC notes no FDA-approved urine mycotoxin test for diagnosing illness from mould exposure, no disease-predictive urinary level, and that low concentrations may occur in healthy people. Analytical detection, including from a CLIA-certified laboratory, therefore does not prove toxic dose, causation, or building contamination.

Practical implications

• Suspected indoor mould should be assessed from the building: inspect for leaks, water damage, condensation, visible mould, and mouldy odour, then correct moisture and remediate contamination as indicated.

Bottom line

• Damp buildings can create ongoing airborne fungal exposure, but urine mycotoxin testing alone cannot identify the source, prove a building is contaminated, or diagnose mould-caused illness.